Population PK Model of Ravulizumab
Indication: Adult paroxysmal nocturnal hemoglobinuria (PNH)
Interactive ravulizumab population PK/PD simulator for adult paroxysmal nocturnal hemoglobinuria based on the FDA BLA 761108 clinical pharmacology review, with weight-band dosing and LDH response modeling.
Drug Overview
Clinical Context
- Molecular Target
- Complement C5
- Drug Class
- Complement C5 inhibitor monoclonal antibody
- Therapeutic Area
- Hematology
- Indication
- Adult paroxysmal nocturnal hemoglobinuria (PNH)
- Route of Administration
- Intravenous infusion
Model Information
- Model Type
- Population PK/PD
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Population allows you to explore concentration-time profiles under different dosing scenarios. The underlying Population PK/PD model characterizes the pharmacokinetics of this complement c5 inhibitor monoclonal antibody following intravenous infusion administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Population PK simulator?
This is a free, interactive pharmacokinetic simulator for Population used in Adult paroxysmal nocturnal hemoglobinuria (PNH). It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Population belong to?
Population is classified as a Complement C5 inhibitor monoclonal antibody that targets Complement C5. It is used in the Hematology therapeutic area.
What route of administration does this model simulate?
This simulator models Intravenous infusion administration of Population. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Population PK/PD model. PK/PD models link drug concentrations to pharmacological effects, allowing exploration of exposure-response relationships.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the Population simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community